Aotearoa New Zealand has embraced self-tests for cervical screening with a University of Otago–Ōtākou Whakaihu Waka-led study proving the method's feasibility.
Apr 17, 2025
0
0
Denmark aims to eradicate cervical cancer by 2040 thanks to a national HPV vaccination campaign and screening program, the Danish Cancer Society said on Monday.
Apr 14, 2025
1
0
New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more ...
Apr 12, 2025
0
0
The first trial of an AI-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine uptake and engagement with health professionals.
Apr 11, 2025
0
18
Anal cancer doesn't get a lot of attention. This may be because it's relatively rare—anal cancer affects an estimated 1 to 2 Australians in every 100,000. As a comparison, melanomas affect about 70 in every 100,000 people.
Apr 9, 2025
0
0
Many symptoms of head and neck cancer are hard to miss—a lump in the neck, persistent hoarseness, a mouth sore that doesn't heal—which is good news for early detection as long as symptoms aren't dismissed.
Apr 6, 2025
0
0
A research team has, for the first time in the world, revealed the identity and differentiation process of human cervical stem cells. The results showed that lactic acid bacteria can inhibit the development of cervical cancer. ...
Mar 24, 2025
0
0
When a person dies, clinicians often look at the cause of death to determine whether it could have been avoided, either by medical prevention such as vaccines or by treatments like antibiotics. These types of deaths are known ...
Mar 24, 2025
0
108
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
Mar 12, 2025
0
0
Evidence relating to barriers to and facilitators of clinical preventive service use in people with disabilities is limited, according to a review published online March 11 in the Annals of Internal Medicine.
Mar 11, 2025
0
0
Cervical cancer is the term for a malignant neoplasm arising from cells originating in the cervix uteri. One of the most common symptoms of cervical cancer is abnormal vaginal bleeding, but in some cases there may be no obvious symptoms until the cancer has progressed to an advanced stage. Treatment usually consists of surgery (including local excision) in early stages, and chemotherapy and/or radiotherapy in more advanced stages of the disease.
Cancer screening using the Pap smear can identify precancerous and potentially precancerous changes in cervical cells and tissue. Treatment of high-grade changes can prevent the development of cancer in many victims. In developed countries, the widespread use of cervical screening programs has reduced the incidence of invasive cervical cancer by 50% or more.[citation needed]
Human papillomavirus (HPV) infection appears to be a necessary factor in the development of almost all cases (90+%) of cervical cancer. HPV vaccines effective against the two strains of this large family of viruses that currently cause approximately 70% of cases of cervical cancer have been licensed in the U.S, Canada, Australia and the EU. Since the vaccines only cover some of the cancer causing ("high-risk") types of HPV, women should seek regular Pap smear screening, even after vaccination.
The cervix is the narrow portion of the uterus where it joins with the top of the vagina. Most cervical cancers are squamous cell carcinomas, arising in the squamous (flattened) epithelial cells that line the cervix. Adenocarcinoma, arising in glandular epithelial cells is the second most common type. Very rarely, cancer can arise in other types of cells in the cervix.
This text uses material from Wikipedia licensed under CC BY-SA
